Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Abstrak
Summary Background For more than three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has provided a framework to quantify health loss due to diseases, injuries, and associated risk factors. This paper presents GBD 2023 findings on disease and injury burden and risk-attributable health loss, offering a global audit of the state of world health to inform public health priorities. This work captures the evolving landscape of health metrics across age groups, sexes, and locations, while reflecting on the remaining post-COVID-19 challenges to achieving our collective global health ambitions. Methods The GBD 2023 combined analysis estimated years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 375 diseases and injuries, and risk-attributable burden associated with 88 modifiable risk factors. Of the more than 310 000 total data sources used for all GBD 2023 (about 30% of which were new to this estimation round), more than 120 000 sources were used for estimation of disease and injury burden and 59 000 for risk factor estimation, and included vital registration systems, surveys, disease registries, and published scientific literature. Data were analysed using previously established modelling approaches, such as disease modelling meta-regression version 2.1 (DisMod-MR 2.1) and comparative risk assessment methods. Diseases and injuries were categorised into four levels on the basis of the established GBD cause hierarchy, as were risk factors using the GBD risk hierarchy. Estimates stratified by age, sex, location, and year from 1990 to 2023 were focused on disease-specific time trends over the 2010–23 period and presented as counts (to three significant figures) and age-standardised rates per 100 000 person-years (to one decimal place). For each measure, 95% uncertainty intervals [UIs] were calculated with the 2·5th and 97·5th percentile ordered values from a 250-draw distribution. Findings Total numbers of global DALYs grew 6·1% (95% UI 4·0–8·1), from 2·64 billion (2·46–2·86) in 2010 to 2·80 billion (2·57–3·08) in 2023, but age-standardised DALY rates, which account for population growth and ageing, decreased by 12·6% (11·0–14·1), revealing large long-term health improvements. Non-communicable diseases (NCDs) contributed 1·45 billion (1·31–1·61) global DALYs in 2010, increasing to 1·80 billion (1·63–2·03) in 2023, alongside a concurrent 4·1% (1·9–6·3) reduction in age-standardised rates. Based on DALY counts, the leading level 3 NCDs in 2023 were ischaemic heart disease (193 million [176–209] DALYs), stroke (157 million [141–172]), and diabetes (90·2 million [75·2–107]), with the largest increases in age-standardised rates since 2010 occurring for anxiety disorders (62·8% [34·0–107·5]), depressive disorders (26·3% [11·6–42·9]), and diabetes (14·9% [7·5–25·6]). Remarkable health gains were made for communicable, maternal, neonatal, and nutritional (CMNN) diseases, with DALYs falling from 874 million (837–917) in 2010 to 681 million (642–736) in 2023, and a 25·8% (22·6–28·7) reduction in age-standardised DALY rates. During the COVID-19 pandemic, DALYs due to CMNN diseases rose but returned to pre-pandemic levels by 2023. From 2010 to 2023, decreases in age-standardised rates for CMNN diseases were led by rate decreases of 49·1% (32·7–61·0) for diarrhoeal diseases, 42·9% (38·0–48·0) for HIV/AIDS, and 42·2% (23·6–56·6) for tuberculosis. Neonatal disorders and lower respiratory infections remained the leading level 3 CMNN causes globally in 2023, although both showed notable rate decreases from 2010, declining by 16·5% (10·6–22·0) and 24·8% (7·4–36·7), respectively. Injury-related age-standardised DALY rates decreased by 15·6% (10·7–19·8) over the same period. Differences in burden due to NCDs, CMNN diseases, and injuries persisted across age, sex, time, and location. Based on our risk analysis, nearly 50% (1·27 billion [1·18–1·38]) of the roughly 2·80 billion total global DALYs in 2023 were attributable to the 88 risk factors analysed in GBD. Globally, the five level 3 risk factors contributing the highest proportion of risk-attributable DALYs were high systolic blood pressure (SBP), particulate matter pollution, high fasting plasma glucose (FPG), smoking, and low birthweight and short gestation—with high SBP accounting for 8·4% (6·9–10·0) of total DALYs. Of the three overarching level 1 GBD risk factor categories—behavioural, metabolic, and environmental and occupational—risk-attributable DALYs rose between 2010 and 2023 only for metabolic risks, increasing by 30·7% (24·8–37·3); however, age-standardised DALY rates attributable to metabolic risks decreased by 6·7% (2·0–11·0) over the same period. For all but three of the 25 leading level 3 risk factors, age-standardised rates dropped between 2010 and 2023—eg, declining by 54·4% (38·7–65·3) for unsafe sanitation, 50·5% (33·3–63·1) for unsafe water source, and 45·2% (25·6–72·0) for no access to handwashing facility, and by 44·9% (37·3–53·5) for child growth failure. The three leading level 3 risk factors for which age-standardised attributable DALY rates rose were high BMI (10·5% [0·1 to 20·9]), drug use (8·4% [2·6 to 15·3]), and high FPG (6·2% [–2·7 to 15·6]; non-significant). Interpretation Our findings underscore the complex and dynamic nature of global health challenges. Since 2010, there have been large decreases in burden due to CMNN diseases and many environmental and behavioural risk factors, juxtaposed with sizeable increases in DALYs attributable to metabolic risk factors and NCDs in growing and ageing populations. This long-observed consequence of the global epidemiological transition was only temporarily interrupted by the COVID-19 pandemic. The substantially decreasing CMNN disease burden, despite the 2008 global financial crisis and pandemic-related disruptions, is one of the greatest collective public health successes known. However, these achievements are at risk of being reversed due to major cuts to development assistance for health globally, the effects of which will hit low-income countries with high burden the hardest. Without sustained investment in evidence-based interventions and policies, progress could stall or reverse, leading to widespread human costs and geopolitical instability. Moreover, the rising NCD burden necessitates intensified efforts to mitigate exposure to leading risk factors—eg, air pollution, smoking, and metabolic risks, such as high SBP, BMI, and FPG—including policies that promote food security, healthier diets, physical activity, and equitable and expanded access to potential treatments, such as GLP-1 receptor agonists. Decisive, coordinated action is needed to address long-standing yet growing health challenges, including depressive and anxiety disorders. Yet this can be only part of the solution. Our response to the NCD syndemic—the complex interaction of multiple health risks, social determinants, and systemic challenges—will define the future landscape of global health. To ensure human wellbeing, economic stability, and social equity, global action to sustain and advance health gains must prioritise reducing disparities by addressing socioeconomic and demographic determinants, ensuring equitable health-care access, tackling malnutrition, strengthening health systems, and improving vaccination coverage. We live in times of great opportunity. Funding Gates Foundation and Bloomberg Philanthropies.
Topik & Kata Kunci
Penulis (500)
S. Hay
K. Ong
D. Santomauro
Bhoomadevi A
M. Aalipour
Hasan Aalruz
H. Ababneh
U. Abaraogu
B. Abate
C. Abbafati
Nasir Abbas
M. Abbasifard
M. Abbasi-Kangevari
S. A. Abd ElHafeez
Ashraf Nabiel Abdalla
Mohammed Altigani Abdalla
E. Abdallah
Barkhad Aden Abdeeq
Nadin M. Abdel Razeq
Ahmed A. Abdelgalil
Reda Abdel-Hameed
Michael Abdelmasseh
Mahmoud H Abdelnabi
Wael M Abdel-Rahman
S. Abd-Elsalam
Sepideh Abdi
Mohammad Abdollahi
M. Abdoun
A. Abdous
J. A. Abdul Aziz
Deldar Morad Abdulah
R. Abdulkader
Adam Abdullahi
Auwal Abdullahi
Toufik Abdul-Rahman
K. Abdykerimova
Habtamu Abebe Getahun
Aidin Abedi
Armita Abedi
Asrat Agalu Abejew
R. A. Abeldaño Zúñiga
E. Abhilash
Shehab Uddin Al Abid
Syed Hani Abidi
Alemwork Abie
O. Abiodun
O. Abiodun
R. Aboagye
S. Abohashem
Hassan Abolhassani
U. S. Abonie
Nagah M. Abourashed
M. Abouzid
Dmitry Abramov
Lucas Guimarães Abreu
Dariush Abtahi
R. Abu Farha
F. Abuadas
A. Abubakar
Bilyaminu Abubakar
Eman Abu-Gharbieh
Sawsan Abuhammad
A. Abuhelwa
Hana J. Abukhadijah
N. Abu-Rmeileh
Salahdein Aburuz
D. Abushanab
R. Achar
Anirudh B Acharya
Apurba Acharya
Ilana N. Ackerman
J. M. Acuna
Ousman Adal
Lisa C. Adams
L. Adamu
M. M. Adane
Zenaw Debasu Addisu
I. Y. Addo
O. Adeagbo
T. A. Adebisi
I. Adedeji
David Adedia
Kamoru A. Adedokun
R. Adedoyin
O. Adegbile
O. Adegboye
N. A. Adegoke
O. Adeleke
Isaac Ayodeji Adesina
M. Adesina
H. Adewuyi
T. Adeyeoluwa
O. Adeyomoye
Kishor Adhikari
R. Adhikary
U. Adiga
M. Adnan
Q. Adnani
P. Adoma
Leticia Akua Adzigbli
David Adzrago
G. Affinito
Ahmed M. Afifi
A. Afolabi
R. Afolabi
Saira Afzal
Gizachew Beykaso Agafari
S. B. Agampodi
Temesgen Anjulo Ageru
Navidha Aggarwal
Mahdi Aghaalikhani
Sepehr Aghajanian
S. K. Aghamir
Cesar Agostinis Sobrinho
Anurag Agrawal
Williams Agyemang-Duah
Mahsa Ahadi
B. Ahinkorah
Aqeel Ahmad
Danish Ahmad
Faisal Ahmad
K. Ahmad
Khurshid Ahmad
Muayyad M. Ahmad
Noah Ahmad
Rabbiya Ahmad
Sajjad Ahmad
Tauseef Ahmad
Waqas Ahmad
Negar Sadat Ahmadi
A. M. Ahmadzade
M. Ahmadzade
A. Ahmed
Anisuddin Ahmed
Ayman Ahmed
Gasha Salih Ahmed
H. Ahmed
Junaid Ahmed
Luai A. Ahmed
Mehrunnisha Ahmed
Meqdad Saleh Ahmed
M. Ahmed
Mushood Ahmed
Oli Ahmed
Shabbir Ahmed
S. Ahmed
G. Aimagambetova
Ahmed AJ Jabbar
D. E. Ajala
Marjan Ajami
A. O. Ajose
Hossein Akbarialiabad
Saeid Akbarifard
Oluwasefunmi Akeju
R. Akhigbe
O. A. Akinkuotu
K. Akinosoglou
M. Akkaif
Sreelatha Akkala
Wole Akosile
Hammad Akram
Ashley E Akrami
R. Akyea
Ala’a Al Amiry
Salah Al Awaidy
S. A. Al Hasan
Omar Al Omari
M. Al Qadire
Omar Al Ta'ani
W. A. Al Taie
Yazan Al Thaher
Omar Ali Mohammed Al Zaabi
Mohammad Ahmmad Mahmoud Al Zoubi
M. Al-Abbadi
Y. Al-Ajlouni
T. Alalwan
Z. Al-Aly
K. Alam
Manjurul Alam
Mohammad Khursheed Alam
Mostafa Alam
Rasmieh M. Al-amer
Abebaw Alamrew
A. Alansari
Turki M. Alanzi
Fahmi Y. Al-Ashwal
R. Al-Asmar
Seyed Mohammad Alavi
Mohammed ALBashtawy
Astefanos Al-Dalakta
Khalifah A. Aldawsari
W. Aldhaleei
M. Aldossary
R. Aldridge
Raouf Alebshehy
Shereen M. Aleidi
Beza Alemayehu
Tekletsadik Tekleslassie Alemayehu
Fentahun Alemnew
Melaku Birhanu Alemu
A. Al-Eyadhy
A. Alfalki
F. Algahtani
A. Algammal
M. Algethami
A. Al-Gheethi
Khairat Al-Habbal
K. Alhabib
N. Alhaji
S. Al-Hajj
F. Alhalaiqa
M. K. Al-Hanawi
Aminu Alhassan Alhassan Ibrahim
Ashraf Alhumaidi
F. Alhumaydhi
Dari Alhuwail
Abid Ali
H. Ali
Irfan Ali
Maratab Ali
Mohammad Ali
M. Ali
Rafat Ali
Shahid Ali
Syed Shujait Shujait Ali
Syed Yusuf Ali
Waad Ali
A. Al-ibraheem
G. Alicandro
Montaha Al-Iede
S. M. Alif
Morteza Alipour
Samah W. Al-Jabi
M. Aljasir
M. Aljofan
Adel Al-Jumaily
S. Aljunid
Ahmad Alkhatib
Mayson H. Alkhatib
Mustafa Alkhawam
Atefeh Allahbakhshian
Khaled S. Allemailem
Mohammed Z Allouh
Wesam Almagharbeh
W. Almahmeed
Sabah Al-Marwani
N. Almasri
Joseph Almazan
Hesham M Al-Mekhlafi
Omar Almidani
Amr Almobayed
K. Alnawafleh
Hasan Y. Alniss
Margret Beaula Alocious Sukumar
Mahmoud A. Alomari
Mohammad R. Alosta
Jaber S. Alqahtani
Saleh A Alqahtani
Mohammad R Alqudimat
A. Al-Qudimat
Ahmad Alrawashdeh
Intima Alrimawi
S. Alrousan
Salman Khalifah Al-Sabah
Mohammed A. Alsabri
Najim Z. Alshahrani
M. Alshehri
Z. Altaany
Awais Altaf
Ala’a B. Al-Tammemi
J. Al-Tawfiq
Malik A Althobiani
K. Altirkawi
J. Álvarez-Gálvez
Vera L Alves Carneiro
N. Alvis-Guzmán
N. Alvis-Zakzuk
Hassan Alwafi
M. Al-Wardat
Y. Al-Worafi
Hany Aly
Mohammad Sharif Ibrahim Alyahya
Amal Alzahmi
H. Alzahrani
K. Alzoubi
Md Akib Al-Zubayer
U. A. Amaechi
Ekiyor Joseph Amafah
Joy Amafah
Masoud Aman mohammadi
Reza Amani-Beni
A. Amegah
F. Amer
Bardia Amidi
A. Amin
T. Amin
Alireza Amindarolzarbi
Saeed Amini
Ehsan Amini-Salehi
Nafiu Aminu
Majid Aminzare
Sohrab Amiri
Joanne O Amlag
D. Amugsi
J. Amzat
F. Anagnostakis
Roshan A. Ananda
R. Ancuceanu
D. Anderlini
David B Anderson
Jason A Anderson
Sofia Androudi
S. Anenberg
Song Peng Ang
Colin Angus
Nguyen Hoang Anh
S. E. Ankomah
Kabilan Annadurai
Amir Anoushiravani
Iman Ansari
Sumbul Ansari
Umair Ansari
Rahel Mulatie Anteneh
Josep M. Antó
C. Antony
E. Antriyandarti
B. Anuoluwa
Saleha Anwar
S. Anwar
R. Anwer
Shahnawaz Anwer
A. Anyasodor
G. L. Apostol
J. P. Arab
Hossein Arabi
J. Arabloo
M. Arafat
Aleksandr Y. Aravkin
D. Areda
J. Arias de la Torre
Hany Ariffin
B. Armocida
Johan Ärnlöv
Jesu Arockiaraj
Mahwish Arooj
A. Artamonov
K. D. Artanti
R. T. Aruleba
Deepavalli Arumuganainar
Nurila Aryntayeva
Mahsa Asadi Anar
Md Asaduzzaman
Syed Mohammad Basherudin Asdaq
Shewatatek Melaku Asefa
Mulu Tiruneh Asemu
Saeed Asgary
M. Asghari-Jafarabadi
Charlie Ashbaugh
Syed Amir Ashraf
Tahira Ashraf
Mitra Ashrafi
M. Ashrafizadeh
B. Asiamah-Asare
M. Aslam
Saeed Aslani
Yuni Asri
B. Assembekov
T. Astell-Burt
Mahshid Ataei
Mirbahador Athari
S. Athari
M. Atout
Sachin R Atre
A. Atreya
Julie Alaere Atta
Zeenah A Atwan
Z. Aumoldaeva
M. Ausloos
Abolfazl Avan
N. Avelar
Sana Javaid Awan
Babafela B Awosile
A. Awotidebe
L. A. Ayana
Seyyed Hamidreza Ayatizadeh
O. Ayinde
Y. Ayipo
S. M. Ayyoubzadeh
Davood Azadi
S. Azadnajafabad
Alireza Azarboo
A. Azargoonjahromi
Masood Azhar
Farya Azimi
Mohd Yusmaidie Aziz
S. Aziz
Amin Azizan
A. Azzam
D. Azzolino
Z. Babandi
Rasha Babiker
G. R. Babu
Israel Tadesse Bacha
Muhammad Badar
A. Badiye
A. A. Badran
Youngoh Bae
Arvind Bagga
Soroush Baghdadi
Nasser Bagheri
Sara Bagheri
Elahe Baghizadeh
Fereshteh Baghizadeh
Sana Baghizadeh
K. Baghlaf
Najmeh Bahmanziari
Mohammad Amin Bahrami
Razieh Bahreini
Ruhai Bai
A. Baig
Vali Baigi
Shankar M. Bakkannavar
A. T. Bako
Senthilkumar Balakrishnan
W. F. Balcha
Maher Balkis
Jose Balmori-de-la-Miyar
Mohammadreza Balooch Hasankhani
Ovidiu Constantin Baltatu
Shatha Bamashmous
Maciej Banach
M. Banakar
Palash Chandra Banik
R. Banik
S. Barati
Noel C Barengo
S. Barker-Collo
H. Barqawi
Ismael A Barreras Beltran
Amadou Barrow
S. Barteit
Lingkan Barua
Md. Abu Bashar
Z. Basharat
Shahid Bashir
Guido Basile
P. Baskaran
Rehana Basri
Quique Bassat
Mohammad-Mahdi Bastan
Sanjay Basu
S. Basu
Kavita Batra
B. Baune
Mahdis Bayat
Mohammad Amin Bayat Tork
Mulat Tirfie Bayih
Feyisa Bayisa
N. Bayleyegn
T. Beaney
Neeraj Bedi
N. Beeraka
Priyamadhaba Behera
Jina Behjati
Babak Behnam
A. Behnoush
B. Bekele
Asnake Gashaw Belayneh
Melesse Belayneh
A. Belete
Gokce Belge Bilgin
Michael Belingheri
M. Bello
O. Bello
Luis Belo
Apostolos Beloukas
S. Bendak
Riyad Bendardaf
C. Benjet
Derrick A. Bennett
Isabela M. Benseñor
Samiun Nazrin Bente Kamal Tune
Habib Benzian
Z. Berezvai
M. Bergami
Alemshet Yirga Berhie
A. Berihun
A. N. Bermudez
Eduardo Bernabé
Robert S. Bernstein
P. J. Bettencourt
A. Bhadoria
A. Bhagavathula
N. Bhala
Jeetendra Bhandari
K. Bhangdia
Ravi G. Bharadwaj
Sonu M M Bhaskar
A. Bhat
Anup Bhat
Format Sitasi
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →- Tahun Terbit
- 2025
- Bahasa
- en
- Total Sitasi
- 82×
- Sumber Database
- Semantic Scholar
- DOI
- 10.1016/s0140-6736(25)01637-x
- Akses
- Open Access ✓